Statistics from Altmetric.com
The following information has been produced for Veterinary Record by the Veterinary Medicines Directorate (VMD) to provide an update for veterinary surgeons on recent changes to marketing authorisations for veterinary medicines in the UK and other relevant issues.
THE points below highlight changes in marketing authorisations that may have a significant impact on veterinary surgeons' prescribing decisions.
New marketing authorisations
New marketing authorisations relevant to veterinary surgeons in the UK that were issued in January 2012 are listed in Table 1. Of the products listed, the following contain active ingredients not previously included in an authorised veterinary medicinal product in the UK:
■ All the ‘Activyl’ products contain indoxacarb (in combination with permethrin); and
■ ‘Startect dual active oral solution for sheep’ contains derquantel (in combination with abamectin).
These products may not yet be readily available in the UK. Veterinary surgeons should contact the marketing authorisation holder directly for details of supply.
Table 1 also indicates where a public assessment report should become available for a product on the VMD's website. Where available, links to these reports are accessible by clicking on the relevant product in the VMD's Product Information Database, www.vmd.defra.gov.uk/ProductInformationDatabase/
The European Medicines Agency (EMA) publishes European Public Assessment Reports (EPARs) for every veterinary medicine that is authorised through a centralised procedure. Links to these reports are …